nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—OPRK1—Progesterone—uterine cancer	0.738	1	CbGbCtD
Nalbuphine—Foetal death—Progesterone—uterine cancer	0.0311	0.119	CcSEcCtD
Nalbuphine—Redness—Progesterone—uterine cancer	0.00531	0.0203	CcSEcCtD
Nalbuphine—Depersonalisation—Progesterone—uterine cancer	0.00512	0.0196	CcSEcCtD
Nalbuphine—Laryngeal oedema—Medroxyprogesterone Acetate—uterine cancer	0.00506	0.0194	CcSEcCtD
Nalbuphine—Speech disorder—Progesterone—uterine cancer	0.00417	0.016	CcSEcCtD
Nalbuphine—Speech disorder—Medroxyprogesterone Acetate—uterine cancer	0.00378	0.0145	CcSEcCtD
Nalbuphine—Warmth—Epirubicin—uterine cancer	0.00324	0.0124	CcSEcCtD
Nalbuphine—Injection site reaction—Medroxyprogesterone Acetate—uterine cancer	0.00323	0.0124	CcSEcCtD
Nalbuphine—Warmth—Doxorubicin—uterine cancer	0.00299	0.0115	CcSEcCtD
Nalbuphine—Swelling—Progesterone—uterine cancer	0.00295	0.0113	CcSEcCtD
Nalbuphine—Euphoric mood—Medroxyprogesterone Acetate—uterine cancer	0.00279	0.0107	CcSEcCtD
Nalbuphine—Swelling—Medroxyprogesterone Acetate—uterine cancer	0.00268	0.0102	CcSEcCtD
Nalbuphine—Cramp muscle—Progesterone—uterine cancer	0.00235	0.00897	CcSEcCtD
Nalbuphine—Tingling sensation—Etoposide—uterine cancer	0.00228	0.00874	CcSEcCtD
Nalbuphine—Asthma—Progesterone—uterine cancer	0.00225	0.00861	CcSEcCtD
Nalbuphine—Numbness—Etoposide—uterine cancer	0.00221	0.00847	CcSEcCtD
Nalbuphine—Sweating increased—Progesterone—uterine cancer	0.00219	0.00839	CcSEcCtD
Nalbuphine—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.00813	CcSEcCtD
Nalbuphine—Sensory loss—Etoposide—uterine cancer	0.00212	0.00811	CcSEcCtD
Nalbuphine—Pollakiuria—Progesterone—uterine cancer	0.00208	0.00796	CcSEcCtD
Nalbuphine—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.0078	CcSEcCtD
Nalbuphine—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.00201	0.00768	CcSEcCtD
Nalbuphine—Depression—Progesterone—uterine cancer	0.002	0.00766	CcSEcCtD
Nalbuphine—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00199	0.0076	CcSEcCtD
Nalbuphine—Body temperature increased—Carboplatin—uterine cancer	0.00193	0.00737	CcSEcCtD
Nalbuphine—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.00188	0.00721	CcSEcCtD
Nalbuphine—Depression—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.00694	CcSEcCtD
Nalbuphine—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00636	CcSEcCtD
Nalbuphine—Erythema—Progesterone—uterine cancer	0.00157	0.006	CcSEcCtD
Nalbuphine—Tension—Progesterone—uterine cancer	0.00154	0.00589	CcSEcCtD
Nalbuphine—Redness—Epirubicin—uterine cancer	0.00152	0.00583	CcSEcCtD
Nalbuphine—Nervousness—Progesterone—uterine cancer	0.00152	0.00583	CcSEcCtD
Nalbuphine—Swelling—Etoposide—uterine cancer	0.00151	0.00578	CcSEcCtD
Nalbuphine—Muscle spasms—Progesterone—uterine cancer	0.00151	0.00577	CcSEcCtD
Nalbuphine—Vision blurred—Progesterone—uterine cancer	0.00148	0.00566	CcSEcCtD
Nalbuphine—Tremor—Progesterone—uterine cancer	0.00147	0.00562	CcSEcCtD
Nalbuphine—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00544	CcSEcCtD
Nalbuphine—Redness—Doxorubicin—uterine cancer	0.00141	0.00539	CcSEcCtD
Nalbuphine—Vertigo—Progesterone—uterine cancer	0.00141	0.00539	CcSEcCtD
Nalbuphine—Syncope—Progesterone—uterine cancer	0.00141	0.00538	CcSEcCtD
Nalbuphine—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00534	CcSEcCtD
Nalbuphine—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00532	CcSEcCtD
Nalbuphine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00528	CcSEcCtD
Nalbuphine—Loss of consciousness—Progesterone—uterine cancer	0.00138	0.00527	CcSEcCtD
Nalbuphine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.00523	CcSEcCtD
Nalbuphine—Convulsion—Progesterone—uterine cancer	0.00136	0.0052	CcSEcCtD
Nalbuphine—Hypertension—Progesterone—uterine cancer	0.00135	0.00518	CcSEcCtD
Nalbuphine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00509	CcSEcCtD
Nalbuphine—Anxiety—Progesterone—uterine cancer	0.00133	0.00509	CcSEcCtD
Nalbuphine—Feeling hot—Epirubicin—uterine cancer	0.00131	0.00501	CcSEcCtD
Nalbuphine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.005	CcSEcCtD
Nalbuphine—Dry mouth—Progesterone—uterine cancer	0.00131	0.005	CcSEcCtD
Nalbuphine—Confusional state—Progesterone—uterine cancer	0.00129	0.00494	CcSEcCtD
Nalbuphine—Oedema—Progesterone—uterine cancer	0.00128	0.0049	CcSEcCtD
Nalbuphine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00489	CcSEcCtD
Nalbuphine—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00488	CcSEcCtD
Nalbuphine—Cardiac arrest—Etoposide—uterine cancer	0.00127	0.00485	CcSEcCtD
Nalbuphine—Shock—Progesterone—uterine cancer	0.00126	0.00482	CcSEcCtD
Nalbuphine—Tachycardia—Progesterone—uterine cancer	0.00125	0.00478	CcSEcCtD
Nalbuphine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00478	CcSEcCtD
Nalbuphine—Hyperhidrosis—Progesterone—uterine cancer	0.00124	0.00473	CcSEcCtD
Nalbuphine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00471	CcSEcCtD
Nalbuphine—Feeling hot—Doxorubicin—uterine cancer	0.00121	0.00464	CcSEcCtD
Nalbuphine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00461	CcSEcCtD
Nalbuphine—Cramp muscle—Etoposide—uterine cancer	0.0012	0.00459	CcSEcCtD
Nalbuphine—Hypotension—Progesterone—uterine cancer	0.0012	0.00458	CcSEcCtD
Nalbuphine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00453	CcSEcCtD
Nalbuphine—Flushing—Dactinomycin—uterine cancer	0.00118	0.00452	CcSEcCtD
Nalbuphine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00447	CcSEcCtD
Nalbuphine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00444	CcSEcCtD
Nalbuphine—Paraesthesia—Progesterone—uterine cancer	0.00115	0.0044	CcSEcCtD
Nalbuphine—Dyspnoea—Progesterone—uterine cancer	0.00114	0.00437	CcSEcCtD
Nalbuphine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00437	CcSEcCtD
Nalbuphine—Somnolence—Progesterone—uterine cancer	0.00114	0.00435	CcSEcCtD
Nalbuphine—Bronchospasm—Etoposide—uterine cancer	0.00113	0.00433	CcSEcCtD
Nalbuphine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00433	CcSEcCtD
Nalbuphine—Dyspepsia—Progesterone—uterine cancer	0.00113	0.00431	CcSEcCtD
Nalbuphine—Sweating increased—Etoposide—uterine cancer	0.00112	0.00429	CcSEcCtD
Nalbuphine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00429	CcSEcCtD
Nalbuphine—Erythema—Dactinomycin—uterine cancer	0.00111	0.00424	CcSEcCtD
Nalbuphine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00415	CcSEcCtD
Nalbuphine—Feeling abnormal—Progesterone—uterine cancer	0.00105	0.00404	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Progesterone—uterine cancer	0.00105	0.004	CcSEcCtD
Nalbuphine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00398	CcSEcCtD
Nalbuphine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00396	CcSEcCtD
Nalbuphine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00395	CcSEcCtD
Nalbuphine—Injection site reaction—Epirubicin—uterine cancer	0.00102	0.00391	CcSEcCtD
Nalbuphine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00391	CcSEcCtD
Nalbuphine—Urticaria—Progesterone—uterine cancer	0.00102	0.00389	CcSEcCtD
Nalbuphine—Body temperature increased—Progesterone—uterine cancer	0.00101	0.00387	CcSEcCtD
Nalbuphine—Abdominal pain—Progesterone—uterine cancer	0.00101	0.00387	CcSEcCtD
Nalbuphine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000956	0.00366	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000948	0.00363	CcSEcCtD
Nalbuphine—Injection site reaction—Doxorubicin—uterine cancer	0.000946	0.00362	CcSEcCtD
Nalbuphine—Hypersensitivity—Progesterone—uterine cancer	0.000943	0.00361	CcSEcCtD
Nalbuphine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000921	0.00353	CcSEcCtD
Nalbuphine—Asthenia—Progesterone—uterine cancer	0.000918	0.00351	CcSEcCtD
Nalbuphine—Hypoaesthesia—Etoposide—uterine cancer	0.000917	0.00351	CcSEcCtD
Nalbuphine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000917	0.00351	CcSEcCtD
Nalbuphine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000917	0.00351	CcSEcCtD
Nalbuphine—Pulmonary oedema—Epirubicin—uterine cancer	0.000916	0.0035	CcSEcCtD
Nalbuphine—Pruritus—Progesterone—uterine cancer	0.000906	0.00346	CcSEcCtD
Nalbuphine—Oedema—Dactinomycin—uterine cancer	0.000905	0.00346	CcSEcCtD
Nalbuphine—Flushing—Etoposide—uterine cancer	0.000855	0.00327	CcSEcCtD
Nalbuphine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000855	0.00327	CcSEcCtD
Nalbuphine—Pulmonary oedema—Doxorubicin—uterine cancer	0.000847	0.00324	CcSEcCtD
Nalbuphine—Dizziness—Progesterone—uterine cancer	0.000846	0.00324	CcSEcCtD
Nalbuphine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000832	0.00318	CcSEcCtD
Nalbuphine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000821	0.00314	CcSEcCtD
Nalbuphine—Vomiting—Progesterone—uterine cancer	0.000814	0.00311	CcSEcCtD
Nalbuphine—Rash—Progesterone—uterine cancer	0.000807	0.00309	CcSEcCtD
Nalbuphine—Dermatitis—Progesterone—uterine cancer	0.000806	0.00308	CcSEcCtD
Nalbuphine—Headache—Progesterone—uterine cancer	0.000802	0.00307	CcSEcCtD
Nalbuphine—Dysgeusia—Etoposide—uterine cancer	0.000786	0.00301	CcSEcCtD
Nalbuphine—Muscle spasms—Etoposide—uterine cancer	0.000771	0.00295	CcSEcCtD
Nalbuphine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000767	0.00293	CcSEcCtD
Nalbuphine—Nausea—Progesterone—uterine cancer	0.00076	0.00291	CcSEcCtD
Nalbuphine—Feeling abnormal—Dactinomycin—uterine cancer	0.000746	0.00285	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00074	0.00283	CcSEcCtD
Nalbuphine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000737	0.00282	CcSEcCtD
Nalbuphine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000731	0.0028	CcSEcCtD
Nalbuphine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000731	0.0028	CcSEcCtD
Nalbuphine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000727	0.00278	CcSEcCtD
Nalbuphine—Vertigo—Etoposide—uterine cancer	0.000721	0.00276	CcSEcCtD
Nalbuphine—Abdominal pain—Dactinomycin—uterine cancer	0.000715	0.00274	CcSEcCtD
Nalbuphine—Body temperature increased—Dactinomycin—uterine cancer	0.000715	0.00274	CcSEcCtD
Nalbuphine—Cardiac arrest—Epirubicin—uterine cancer	0.00071	0.00272	CcSEcCtD
Nalbuphine—Loss of consciousness—Etoposide—uterine cancer	0.000705	0.0027	CcSEcCtD
Nalbuphine—Convulsion—Etoposide—uterine cancer	0.000695	0.00266	CcSEcCtD
Nalbuphine—Hypertension—Etoposide—uterine cancer	0.000693	0.00265	CcSEcCtD
Nalbuphine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000689	0.00264	CcSEcCtD
Nalbuphine—Hypersensitivity—Dactinomycin—uterine cancer	0.000667	0.00255	CcSEcCtD
Nalbuphine—Confusional state—Etoposide—uterine cancer	0.00066	0.00253	CcSEcCtD
Nalbuphine—Cardiac arrest—Doxorubicin—uterine cancer	0.000657	0.00251	CcSEcCtD
Nalbuphine—Asthenia—Dactinomycin—uterine cancer	0.000649	0.00248	CcSEcCtD
Nalbuphine—Asthma—Epirubicin—uterine cancer	0.000645	0.00247	CcSEcCtD
Nalbuphine—Tachycardia—Etoposide—uterine cancer	0.000639	0.00245	CcSEcCtD
Nalbuphine—Hyperhidrosis—Etoposide—uterine cancer	0.000633	0.00242	CcSEcCtD
Nalbuphine—Hypotension—Etoposide—uterine cancer	0.000612	0.00234	CcSEcCtD
Nalbuphine—Asthma—Doxorubicin—uterine cancer	0.000597	0.00228	CcSEcCtD
Nalbuphine—Pollakiuria—Epirubicin—uterine cancer	0.000596	0.00228	CcSEcCtD
Nalbuphine—Paraesthesia—Etoposide—uterine cancer	0.000588	0.00225	CcSEcCtD
Nalbuphine—Dyspnoea—Etoposide—uterine cancer	0.000584	0.00223	CcSEcCtD
Nalbuphine—Somnolence—Etoposide—uterine cancer	0.000582	0.00223	CcSEcCtD
Nalbuphine—Vomiting—Dactinomycin—uterine cancer	0.000575	0.0022	CcSEcCtD
Nalbuphine—Rash—Dactinomycin—uterine cancer	0.00057	0.00218	CcSEcCtD
Nalbuphine—Pollakiuria—Doxorubicin—uterine cancer	0.000552	0.00211	CcSEcCtD
Nalbuphine—Feeling abnormal—Etoposide—uterine cancer	0.00054	0.00206	CcSEcCtD
Nalbuphine—Nausea—Dactinomycin—uterine cancer	0.000537	0.00206	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Etoposide—uterine cancer	0.000535	0.00205	CcSEcCtD
Nalbuphine—Bradycardia—Epirubicin—uterine cancer	0.000526	0.00201	CcSEcCtD
Nalbuphine—Urticaria—Etoposide—uterine cancer	0.00052	0.00199	CcSEcCtD
Nalbuphine—Abdominal pain—Etoposide—uterine cancer	0.000518	0.00198	CcSEcCtD
Nalbuphine—Body temperature increased—Etoposide—uterine cancer	0.000518	0.00198	CcSEcCtD
Nalbuphine—Hypoaesthesia—Epirubicin—uterine cancer	0.000514	0.00197	CcSEcCtD
Nalbuphine—Bradycardia—Doxorubicin—uterine cancer	0.000487	0.00186	CcSEcCtD
Nalbuphine—Hypersensitivity—Etoposide—uterine cancer	0.000482	0.00185	CcSEcCtD
Nalbuphine—Flushing—Epirubicin—uterine cancer	0.000479	0.00183	CcSEcCtD
Nalbuphine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000476	0.00182	CcSEcCtD
Nalbuphine—Asthenia—Etoposide—uterine cancer	0.00047	0.0018	CcSEcCtD
Nalbuphine—Pruritus—Etoposide—uterine cancer	0.000463	0.00177	CcSEcCtD
Nalbuphine—Erythema—Epirubicin—uterine cancer	0.00045	0.00172	CcSEcCtD
Nalbuphine—Flushing—Doxorubicin—uterine cancer	0.000444	0.0017	CcSEcCtD
Nalbuphine—Tension—Epirubicin—uterine cancer	0.000441	0.00169	CcSEcCtD
Nalbuphine—Dysgeusia—Epirubicin—uterine cancer	0.00044	0.00168	CcSEcCtD
Nalbuphine—Nervousness—Epirubicin—uterine cancer	0.000437	0.00167	CcSEcCtD
Nalbuphine—Dizziness—Etoposide—uterine cancer	0.000433	0.00166	CcSEcCtD
Nalbuphine—Muscle spasms—Epirubicin—uterine cancer	0.000432	0.00165	CcSEcCtD
Nalbuphine—Vision blurred—Epirubicin—uterine cancer	0.000424	0.00162	CcSEcCtD
Nalbuphine—Vomiting—Etoposide—uterine cancer	0.000416	0.00159	CcSEcCtD
Nalbuphine—Erythema—Doxorubicin—uterine cancer	0.000416	0.00159	CcSEcCtD
Nalbuphine—Agitation—Epirubicin—uterine cancer	0.000413	0.00158	CcSEcCtD
Nalbuphine—Rash—Etoposide—uterine cancer	0.000413	0.00158	CcSEcCtD
Nalbuphine—Dermatitis—Etoposide—uterine cancer	0.000412	0.00158	CcSEcCtD
Nalbuphine—Headache—Etoposide—uterine cancer	0.00041	0.00157	CcSEcCtD
Nalbuphine—Tension—Doxorubicin—uterine cancer	0.000408	0.00156	CcSEcCtD
Nalbuphine—Dysgeusia—Doxorubicin—uterine cancer	0.000408	0.00156	CcSEcCtD
Nalbuphine—Nervousness—Doxorubicin—uterine cancer	0.000404	0.00155	CcSEcCtD
Nalbuphine—Vertigo—Epirubicin—uterine cancer	0.000404	0.00155	CcSEcCtD
Nalbuphine—Syncope—Epirubicin—uterine cancer	0.000403	0.00154	CcSEcCtD
Nalbuphine—Muscle spasms—Doxorubicin—uterine cancer	0.0004	0.00153	CcSEcCtD
Nalbuphine—Loss of consciousness—Epirubicin—uterine cancer	0.000395	0.00151	CcSEcCtD
Nalbuphine—Vision blurred—Doxorubicin—uterine cancer	0.000392	0.0015	CcSEcCtD
Nalbuphine—Convulsion—Epirubicin—uterine cancer	0.00039	0.00149	CcSEcCtD
Nalbuphine—Nausea—Etoposide—uterine cancer	0.000389	0.00149	CcSEcCtD
Nalbuphine—Hypertension—Epirubicin—uterine cancer	0.000388	0.00149	CcSEcCtD
Nalbuphine—Agitation—Doxorubicin—uterine cancer	0.000382	0.00146	CcSEcCtD
Nalbuphine—Anxiety—Epirubicin—uterine cancer	0.000382	0.00146	CcSEcCtD
Nalbuphine—Dry mouth—Epirubicin—uterine cancer	0.000374	0.00143	CcSEcCtD
Nalbuphine—Vertigo—Doxorubicin—uterine cancer	0.000374	0.00143	CcSEcCtD
Nalbuphine—Syncope—Doxorubicin—uterine cancer	0.000373	0.00143	CcSEcCtD
Nalbuphine—Confusional state—Epirubicin—uterine cancer	0.00037	0.00142	CcSEcCtD
Nalbuphine—Oedema—Epirubicin—uterine cancer	0.000367	0.0014	CcSEcCtD
Nalbuphine—Loss of consciousness—Doxorubicin—uterine cancer	0.000366	0.0014	CcSEcCtD
Nalbuphine—Shock—Epirubicin—uterine cancer	0.000361	0.00138	CcSEcCtD
Nalbuphine—Convulsion—Doxorubicin—uterine cancer	0.000361	0.00138	CcSEcCtD
Nalbuphine—Hypertension—Doxorubicin—uterine cancer	0.000359	0.00137	CcSEcCtD
Nalbuphine—Tachycardia—Epirubicin—uterine cancer	0.000358	0.00137	CcSEcCtD
Nalbuphine—Hyperhidrosis—Epirubicin—uterine cancer	0.000355	0.00136	CcSEcCtD
Nalbuphine—Anxiety—Doxorubicin—uterine cancer	0.000353	0.00135	CcSEcCtD
Nalbuphine—Dry mouth—Doxorubicin—uterine cancer	0.000346	0.00133	CcSEcCtD
Nalbuphine—Hypotension—Epirubicin—uterine cancer	0.000343	0.00131	CcSEcCtD
Nalbuphine—Confusional state—Doxorubicin—uterine cancer	0.000342	0.00131	CcSEcCtD
Nalbuphine—Oedema—Doxorubicin—uterine cancer	0.00034	0.0013	CcSEcCtD
Nalbuphine—Shock—Doxorubicin—uterine cancer	0.000334	0.00128	CcSEcCtD
Nalbuphine—Tachycardia—Doxorubicin—uterine cancer	0.000331	0.00127	CcSEcCtD
Nalbuphine—Paraesthesia—Epirubicin—uterine cancer	0.00033	0.00126	CcSEcCtD
Nalbuphine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000328	0.00126	CcSEcCtD
Nalbuphine—Dyspnoea—Epirubicin—uterine cancer	0.000327	0.00125	CcSEcCtD
Nalbuphine—Somnolence—Epirubicin—uterine cancer	0.000326	0.00125	CcSEcCtD
Nalbuphine—Dyspepsia—Epirubicin—uterine cancer	0.000323	0.00124	CcSEcCtD
Nalbuphine—Hypotension—Doxorubicin—uterine cancer	0.000317	0.00121	CcSEcCtD
Nalbuphine—Paraesthesia—Doxorubicin—uterine cancer	0.000305	0.00117	CcSEcCtD
Nalbuphine—Dyspnoea—Doxorubicin—uterine cancer	0.000303	0.00116	CcSEcCtD
Nalbuphine—Feeling abnormal—Epirubicin—uterine cancer	0.000302	0.00116	CcSEcCtD
Nalbuphine—Somnolence—Doxorubicin—uterine cancer	0.000302	0.00116	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Epirubicin—uterine cancer	0.0003	0.00115	CcSEcCtD
Nalbuphine—Dyspepsia—Doxorubicin—uterine cancer	0.000299	0.00114	CcSEcCtD
Nalbuphine—Urticaria—Epirubicin—uterine cancer	0.000292	0.00112	CcSEcCtD
Nalbuphine—Abdominal pain—Epirubicin—uterine cancer	0.00029	0.00111	CcSEcCtD
Nalbuphine—Body temperature increased—Epirubicin—uterine cancer	0.00029	0.00111	CcSEcCtD
Nalbuphine—Feeling abnormal—Doxorubicin—uterine cancer	0.00028	0.00107	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000278	0.00106	CcSEcCtD
Nalbuphine—Naloxone—ESR1—uterine cancer	0.000274	1	CrCbGaD
Nalbuphine—Hypersensitivity—Epirubicin—uterine cancer	0.00027	0.00103	CcSEcCtD
Nalbuphine—Urticaria—Doxorubicin—uterine cancer	0.00027	0.00103	CcSEcCtD
Nalbuphine—Body temperature increased—Doxorubicin—uterine cancer	0.000268	0.00103	CcSEcCtD
Nalbuphine—Abdominal pain—Doxorubicin—uterine cancer	0.000268	0.00103	CcSEcCtD
Nalbuphine—Asthenia—Epirubicin—uterine cancer	0.000263	0.00101	CcSEcCtD
Nalbuphine—Pruritus—Epirubicin—uterine cancer	0.00026	0.000994	CcSEcCtD
Nalbuphine—Hypersensitivity—Doxorubicin—uterine cancer	0.00025	0.000957	CcSEcCtD
Nalbuphine—Asthenia—Doxorubicin—uterine cancer	0.000244	0.000932	CcSEcCtD
Nalbuphine—Dizziness—Epirubicin—uterine cancer	0.000243	0.000929	CcSEcCtD
Nalbuphine—Pruritus—Doxorubicin—uterine cancer	0.00024	0.000919	CcSEcCtD
Nalbuphine—Vomiting—Epirubicin—uterine cancer	0.000233	0.000893	CcSEcCtD
Nalbuphine—Rash—Epirubicin—uterine cancer	0.000231	0.000885	CcSEcCtD
Nalbuphine—Dermatitis—Epirubicin—uterine cancer	0.000231	0.000885	CcSEcCtD
Nalbuphine—Headache—Epirubicin—uterine cancer	0.00023	0.00088	CcSEcCtD
Nalbuphine—Dizziness—Doxorubicin—uterine cancer	0.000225	0.000859	CcSEcCtD
Nalbuphine—Nausea—Epirubicin—uterine cancer	0.000218	0.000834	CcSEcCtD
Nalbuphine—Vomiting—Doxorubicin—uterine cancer	0.000216	0.000826	CcSEcCtD
Nalbuphine—Rash—Doxorubicin—uterine cancer	0.000214	0.000819	CcSEcCtD
Nalbuphine—Dermatitis—Doxorubicin—uterine cancer	0.000214	0.000819	CcSEcCtD
Nalbuphine—Headache—Doxorubicin—uterine cancer	0.000213	0.000814	CcSEcCtD
Nalbuphine—Nausea—Doxorubicin—uterine cancer	0.000202	0.000772	CcSEcCtD
